C2N Diagnostics, LLC
2 private offerings reported to the SEC on Form D since 2016, $35.0M sold in all. Biotech, MO.
- Form D offerings: 2
- Reported sold: $35.0M
- Newest: May 30, 2025
- FDA records: Company page
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| May 30, 2025 | $10.0M | $10.0M | C2N Diagnostics, LLCBiotech · MO | Not amended | 0002021597-25-000002 |
| May 6, 2024 | $25.0M | $25.0M | C2N Diagnostics, LLCBiotech · MO | Sep 26, 2024 | 0002021597-24-000001 |
SEC Profile
From the company's EDGAR record- Business address
- St. Louis, Mo
- Incorporated in
- DE
- All SEC filings
- CIK 2021597 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR